InsidersTradesSigma
Xbrane Biopharma AB: directors' dealings · Finland · FIN-FSA
FI:xbrane-biopharma-abSE0026598583FI·FIN-FSAMcap 228M€Healthcare
Explore the full management transaction log of Xbrane Biopharma AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Xbrane Biopharma AB has recorded 1 public disclosures. Market capitalisation: €227.7m. The latest transaction was filed on 28 October 2025 (Sale). Among the most active insiders: Siavash Bashiri. Every trade is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€4,647
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
11.05 €
Analyst consensus
1 analystsStrong buy
15.00 €Target 15.00 €(+36%)15.00 €
Income statement
Revenue152.4 M€
Gross profit89.5 M€59% margin
Net income127.2 M€138.7% margin
Valuation
P/Book0.4x
Beta0.89
Balance sheet & cash
Market cap227.7 M€
Total debt58.3 M€
Free Cash Flow−390.3 M€
Debt / Equity10%
Profitability & ownership
ROE-20.4%
ROA-5.2%
% insiders41.0%
% institutions6.3%
Last declaration on 28 October 2025
Declarations0 total
No declarations found
0 of 0 declarations